The retail pharmacy sector is increasingly exposed to the volatility and fragility of the global pharmaceutical supply chain, with recurring **drug shortages** becoming a persistent clinical and operational challenge. These shortages, often involving high-demand generics, injectables, or critical active pharmaceutical ingredients (APIs) sourced from a limited number of overseas manufacturers,...